Sterile Inflammation in Acetaminophen-induced Liver Injury Is Mediated by Cot/tpl2
Cot/tpl2 (MAP3K8) activates MKK1/2-Erk1/2 following stimulation of the Toll-like/IL-1 receptor superfamily. Here, we investigated the role of Cot/tpl2 in sterile inflammation and drug-induced liver toxicity. Cot/tpl2 KO mice exhibited reduced hepatic injury after acetaminophen challenge, as evidence...
Gespeichert in:
Veröffentlicht in: | The Journal of biological chemistry 2013-05, Vol.288 (21), p.15342-15351 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 15351 |
---|---|
container_issue | 21 |
container_start_page | 15342 |
container_title | The Journal of biological chemistry |
container_volume | 288 |
creator | Sanz-Garcia, Carlos Ferrer-Mayorga, Gemma González-Rodríguez, Águeda Valverde, Ángela M. Martín-Duce, Antonio Velasco-Martín, Juan P. Regadera, Javier Fernández, Margarita Alemany, Susana |
description | Cot/tpl2 (MAP3K8) activates MKK1/2-Erk1/2 following stimulation of the Toll-like/IL-1 receptor superfamily. Here, we investigated the role of Cot/tpl2 in sterile inflammation and drug-induced liver toxicity. Cot/tpl2 KO mice exhibited reduced hepatic injury after acetaminophen challenge, as evidenced by decreased serum levels of both alanine and aspartate aminotransferases, decreased hepatic necrosis, and increased survival relative to Wt mice. Serum levels of both alanine and aspartate aminotransferases were also lower after intraperitoneal injection of acetaminophen in mice expressing an inactive form of Cot/tpl2 compared with Wt mice, suggesting that Cot/tpl2 activity contributes to acetaminophen-induced liver injury. Furthermore, Cot/tpl2 deficiency reduced neutrophil and macrophage infiltration in the liver of mice treated with acetaminophen, as well as their hepatic and systemic levels of IL-1α. Intraperitoneal injection of damage-associated molecular patterns from necrotic hepatocytes also impaired the recruitment of leukocytes and decreased the levels of several cytokines in the peritoneal cavity in Cot/tpl2 KO mice compared with Wt counterparts. Moreover, similar activation profiles of intracellular pathways were observed in Wt macrophages stimulated with Wt or Cot/tpl2 KO damage-associated molecular patterns. However, upon stimulation with damage-associated molecular patterns, the activation of Erk1/2 and JNK was deficient in Cot/tpl2 KO macrophages compared with their Wt counterparts; an effect accompanied by weaker release of several cytokines, including IL-1α, an important component in the development of sterile inflammation. Taken together, these findings indicate that Cot/tpl2 contributes to acetaminophen-induced liver injury, providing some insight into the underlying molecular mechanisms.
Background: MAP3K8 (Cot/tpl2) activates MKK1/2-Erk1/2 upon stimulation of receptors from the Toll-like/interleukin-1 receptor superfamily.
Results: Cot/tpl2 plays an essential role in acetaminophen-induced liver injury by modulating the generation of inflammatory signals induced by necrotic cells.
Conclusion: Sterile inflammatory processes triggered by tissue damage are modulated by Cot/tpl2.
Significance: Cot/tpl2 contributes to the development of pathologies associated with inflammation triggered by damage-associated molecular patterns. |
doi_str_mv | 10.1074/jbc.M112.439547 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3663553</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925820460697</els_id><sourcerecordid>23572518</sourcerecordid><originalsourceid>FETCH-LOGICAL-c489t-1f1f03f54f5c4a64bf519f77be3d9af88eee2f26bc9a756b153f7675f6005e6e3</originalsourceid><addsrcrecordid>eNp1kFtLwzAUx4Mobk6ffZN-gW5J07TNizCGl8FE8AK-hTQ9cRltWtJssG9vRnXog-flPPwvh_ND6JrgKcF5OtuUavpESDJNKWdpfoLGBBc0pox8nKIxxgmJecKKEbro-w0Ok3JyjkYJZXnCSDFGL68enKkhWlpdy6aR3rQ2MjaaK_CyMbbt1mBjY6utgipamR244N1s3T5a9tETVEb6IJT7aNH6me_q5BKdaVn3cPW9J-j9_u5t8Rivnh-Wi_kqVmnBfUw00ZhqlmqmUpmlpWaE6zwvgVZc6qIAgEQnWam4zFlWEkZ1nuVMZxgzyIBO0O3Q223LBioF1jtZi86ZRrq9aKURfxVr1uKz3QmaZZQxGgpmQ4Fybd870McsweKAVwS84oBXDHhD4ub3yaP_h2cw8MEA4fGdASd6ZcAGdMaB8qJqzb_lXwzIi3Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Sterile Inflammation in Acetaminophen-induced Liver Injury Is Mediated by Cot/tpl2</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Sanz-Garcia, Carlos ; Ferrer-Mayorga, Gemma ; González-Rodríguez, Águeda ; Valverde, Ángela M. ; Martín-Duce, Antonio ; Velasco-Martín, Juan P. ; Regadera, Javier ; Fernández, Margarita ; Alemany, Susana</creator><creatorcontrib>Sanz-Garcia, Carlos ; Ferrer-Mayorga, Gemma ; González-Rodríguez, Águeda ; Valverde, Ángela M. ; Martín-Duce, Antonio ; Velasco-Martín, Juan P. ; Regadera, Javier ; Fernández, Margarita ; Alemany, Susana</creatorcontrib><description>Cot/tpl2 (MAP3K8) activates MKK1/2-Erk1/2 following stimulation of the Toll-like/IL-1 receptor superfamily. Here, we investigated the role of Cot/tpl2 in sterile inflammation and drug-induced liver toxicity. Cot/tpl2 KO mice exhibited reduced hepatic injury after acetaminophen challenge, as evidenced by decreased serum levels of both alanine and aspartate aminotransferases, decreased hepatic necrosis, and increased survival relative to Wt mice. Serum levels of both alanine and aspartate aminotransferases were also lower after intraperitoneal injection of acetaminophen in mice expressing an inactive form of Cot/tpl2 compared with Wt mice, suggesting that Cot/tpl2 activity contributes to acetaminophen-induced liver injury. Furthermore, Cot/tpl2 deficiency reduced neutrophil and macrophage infiltration in the liver of mice treated with acetaminophen, as well as their hepatic and systemic levels of IL-1α. Intraperitoneal injection of damage-associated molecular patterns from necrotic hepatocytes also impaired the recruitment of leukocytes and decreased the levels of several cytokines in the peritoneal cavity in Cot/tpl2 KO mice compared with Wt counterparts. Moreover, similar activation profiles of intracellular pathways were observed in Wt macrophages stimulated with Wt or Cot/tpl2 KO damage-associated molecular patterns. However, upon stimulation with damage-associated molecular patterns, the activation of Erk1/2 and JNK was deficient in Cot/tpl2 KO macrophages compared with their Wt counterparts; an effect accompanied by weaker release of several cytokines, including IL-1α, an important component in the development of sterile inflammation. Taken together, these findings indicate that Cot/tpl2 contributes to acetaminophen-induced liver injury, providing some insight into the underlying molecular mechanisms.
Background: MAP3K8 (Cot/tpl2) activates MKK1/2-Erk1/2 upon stimulation of receptors from the Toll-like/interleukin-1 receptor superfamily.
Results: Cot/tpl2 plays an essential role in acetaminophen-induced liver injury by modulating the generation of inflammatory signals induced by necrotic cells.
Conclusion: Sterile inflammatory processes triggered by tissue damage are modulated by Cot/tpl2.
Significance: Cot/tpl2 contributes to the development of pathologies associated with inflammation triggered by damage-associated molecular patterns.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M112.439547</identifier><identifier>PMID: 23572518</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Acetaminophen - adverse effects ; Acetaminophen - pharmacology ; Alanine Transaminase - blood ; Alanine Transaminase - genetics ; Analgesics, Non-Narcotic - adverse effects ; Analgesics, Non-Narcotic - pharmacology ; Animals ; Aspartate Aminotransferases - blood ; Aspartate Aminotransferases - genetics ; Cell Line, Transformed ; Chemical and Drug Induced Liver Injury - enzymology ; Chemical and Drug Induced Liver Injury - genetics ; Chemical and Drug Induced Liver Injury - pathology ; Cytokine ; Drug Action ; ERK ; Hepatocyte ; Inflammation ; Interleukin-1alpha - genetics ; Interleukin-1alpha - metabolism ; Leukocyte ; Liver - enzymology ; Liver - pathology ; Liver Injury ; Macrophages ; Macrophages - enzymology ; Macrophages - pathology ; MAP Kinase Kinase 4 - genetics ; MAP Kinase Kinase 4 - metabolism ; MAP Kinase Kinase Kinases - genetics ; MAP Kinase Kinase Kinases - metabolism ; MAP Kinase Signaling System - drug effects ; MAP Kinase Signaling System - genetics ; Mice ; Mice, Knockout ; Mitogen-Activated Protein Kinase 3 - genetics ; Mitogen-Activated Protein Kinase 3 - metabolism ; Molecular Bases of Disease ; Necrosis (Necrotic Death) ; Neutrophil Infiltration - drug effects ; Neutrophil Infiltration - genetics ; Neutrophils - enzymology ; Neutrophils - pathology ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins - metabolism</subject><ispartof>The Journal of biological chemistry, 2013-05, Vol.288 (21), p.15342-15351</ispartof><rights>2013 © 2013 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><rights>2013 by The American Society for Biochemistry and Molecular Biology, Inc. 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c489t-1f1f03f54f5c4a64bf519f77be3d9af88eee2f26bc9a756b153f7675f6005e6e3</citedby><cites>FETCH-LOGICAL-c489t-1f1f03f54f5c4a64bf519f77be3d9af88eee2f26bc9a756b153f7675f6005e6e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663553/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663553/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23572518$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sanz-Garcia, Carlos</creatorcontrib><creatorcontrib>Ferrer-Mayorga, Gemma</creatorcontrib><creatorcontrib>González-Rodríguez, Águeda</creatorcontrib><creatorcontrib>Valverde, Ángela M.</creatorcontrib><creatorcontrib>Martín-Duce, Antonio</creatorcontrib><creatorcontrib>Velasco-Martín, Juan P.</creatorcontrib><creatorcontrib>Regadera, Javier</creatorcontrib><creatorcontrib>Fernández, Margarita</creatorcontrib><creatorcontrib>Alemany, Susana</creatorcontrib><title>Sterile Inflammation in Acetaminophen-induced Liver Injury Is Mediated by Cot/tpl2</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Cot/tpl2 (MAP3K8) activates MKK1/2-Erk1/2 following stimulation of the Toll-like/IL-1 receptor superfamily. Here, we investigated the role of Cot/tpl2 in sterile inflammation and drug-induced liver toxicity. Cot/tpl2 KO mice exhibited reduced hepatic injury after acetaminophen challenge, as evidenced by decreased serum levels of both alanine and aspartate aminotransferases, decreased hepatic necrosis, and increased survival relative to Wt mice. Serum levels of both alanine and aspartate aminotransferases were also lower after intraperitoneal injection of acetaminophen in mice expressing an inactive form of Cot/tpl2 compared with Wt mice, suggesting that Cot/tpl2 activity contributes to acetaminophen-induced liver injury. Furthermore, Cot/tpl2 deficiency reduced neutrophil and macrophage infiltration in the liver of mice treated with acetaminophen, as well as their hepatic and systemic levels of IL-1α. Intraperitoneal injection of damage-associated molecular patterns from necrotic hepatocytes also impaired the recruitment of leukocytes and decreased the levels of several cytokines in the peritoneal cavity in Cot/tpl2 KO mice compared with Wt counterparts. Moreover, similar activation profiles of intracellular pathways were observed in Wt macrophages stimulated with Wt or Cot/tpl2 KO damage-associated molecular patterns. However, upon stimulation with damage-associated molecular patterns, the activation of Erk1/2 and JNK was deficient in Cot/tpl2 KO macrophages compared with their Wt counterparts; an effect accompanied by weaker release of several cytokines, including IL-1α, an important component in the development of sterile inflammation. Taken together, these findings indicate that Cot/tpl2 contributes to acetaminophen-induced liver injury, providing some insight into the underlying molecular mechanisms.
Background: MAP3K8 (Cot/tpl2) activates MKK1/2-Erk1/2 upon stimulation of receptors from the Toll-like/interleukin-1 receptor superfamily.
Results: Cot/tpl2 plays an essential role in acetaminophen-induced liver injury by modulating the generation of inflammatory signals induced by necrotic cells.
Conclusion: Sterile inflammatory processes triggered by tissue damage are modulated by Cot/tpl2.
Significance: Cot/tpl2 contributes to the development of pathologies associated with inflammation triggered by damage-associated molecular patterns.</description><subject>Acetaminophen - adverse effects</subject><subject>Acetaminophen - pharmacology</subject><subject>Alanine Transaminase - blood</subject><subject>Alanine Transaminase - genetics</subject><subject>Analgesics, Non-Narcotic - adverse effects</subject><subject>Analgesics, Non-Narcotic - pharmacology</subject><subject>Animals</subject><subject>Aspartate Aminotransferases - blood</subject><subject>Aspartate Aminotransferases - genetics</subject><subject>Cell Line, Transformed</subject><subject>Chemical and Drug Induced Liver Injury - enzymology</subject><subject>Chemical and Drug Induced Liver Injury - genetics</subject><subject>Chemical and Drug Induced Liver Injury - pathology</subject><subject>Cytokine</subject><subject>Drug Action</subject><subject>ERK</subject><subject>Hepatocyte</subject><subject>Inflammation</subject><subject>Interleukin-1alpha - genetics</subject><subject>Interleukin-1alpha - metabolism</subject><subject>Leukocyte</subject><subject>Liver - enzymology</subject><subject>Liver - pathology</subject><subject>Liver Injury</subject><subject>Macrophages</subject><subject>Macrophages - enzymology</subject><subject>Macrophages - pathology</subject><subject>MAP Kinase Kinase 4 - genetics</subject><subject>MAP Kinase Kinase 4 - metabolism</subject><subject>MAP Kinase Kinase Kinases - genetics</subject><subject>MAP Kinase Kinase Kinases - metabolism</subject><subject>MAP Kinase Signaling System - drug effects</subject><subject>MAP Kinase Signaling System - genetics</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Mitogen-Activated Protein Kinase 3 - genetics</subject><subject>Mitogen-Activated Protein Kinase 3 - metabolism</subject><subject>Molecular Bases of Disease</subject><subject>Necrosis (Necrotic Death)</subject><subject>Neutrophil Infiltration - drug effects</subject><subject>Neutrophil Infiltration - genetics</subject><subject>Neutrophils - enzymology</subject><subject>Neutrophils - pathology</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins - metabolism</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kFtLwzAUx4Mobk6ffZN-gW5J07TNizCGl8FE8AK-hTQ9cRltWtJssG9vRnXog-flPPwvh_ND6JrgKcF5OtuUavpESDJNKWdpfoLGBBc0pox8nKIxxgmJecKKEbro-w0Ok3JyjkYJZXnCSDFGL68enKkhWlpdy6aR3rQ2MjaaK_CyMbbt1mBjY6utgipamR244N1s3T5a9tETVEb6IJT7aNH6me_q5BKdaVn3cPW9J-j9_u5t8Rivnh-Wi_kqVmnBfUw00ZhqlmqmUpmlpWaE6zwvgVZc6qIAgEQnWam4zFlWEkZ1nuVMZxgzyIBO0O3Q223LBioF1jtZi86ZRrq9aKURfxVr1uKz3QmaZZQxGgpmQ4Fybd870McsweKAVwS84oBXDHhD4ub3yaP_h2cw8MEA4fGdASd6ZcAGdMaB8qJqzb_lXwzIi3Y</recordid><startdate>20130524</startdate><enddate>20130524</enddate><creator>Sanz-Garcia, Carlos</creator><creator>Ferrer-Mayorga, Gemma</creator><creator>González-Rodríguez, Águeda</creator><creator>Valverde, Ángela M.</creator><creator>Martín-Duce, Antonio</creator><creator>Velasco-Martín, Juan P.</creator><creator>Regadera, Javier</creator><creator>Fernández, Margarita</creator><creator>Alemany, Susana</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20130524</creationdate><title>Sterile Inflammation in Acetaminophen-induced Liver Injury Is Mediated by Cot/tpl2</title><author>Sanz-Garcia, Carlos ; Ferrer-Mayorga, Gemma ; González-Rodríguez, Águeda ; Valverde, Ángela M. ; Martín-Duce, Antonio ; Velasco-Martín, Juan P. ; Regadera, Javier ; Fernández, Margarita ; Alemany, Susana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c489t-1f1f03f54f5c4a64bf519f77be3d9af88eee2f26bc9a756b153f7675f6005e6e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acetaminophen - adverse effects</topic><topic>Acetaminophen - pharmacology</topic><topic>Alanine Transaminase - blood</topic><topic>Alanine Transaminase - genetics</topic><topic>Analgesics, Non-Narcotic - adverse effects</topic><topic>Analgesics, Non-Narcotic - pharmacology</topic><topic>Animals</topic><topic>Aspartate Aminotransferases - blood</topic><topic>Aspartate Aminotransferases - genetics</topic><topic>Cell Line, Transformed</topic><topic>Chemical and Drug Induced Liver Injury - enzymology</topic><topic>Chemical and Drug Induced Liver Injury - genetics</topic><topic>Chemical and Drug Induced Liver Injury - pathology</topic><topic>Cytokine</topic><topic>Drug Action</topic><topic>ERK</topic><topic>Hepatocyte</topic><topic>Inflammation</topic><topic>Interleukin-1alpha - genetics</topic><topic>Interleukin-1alpha - metabolism</topic><topic>Leukocyte</topic><topic>Liver - enzymology</topic><topic>Liver - pathology</topic><topic>Liver Injury</topic><topic>Macrophages</topic><topic>Macrophages - enzymology</topic><topic>Macrophages - pathology</topic><topic>MAP Kinase Kinase 4 - genetics</topic><topic>MAP Kinase Kinase 4 - metabolism</topic><topic>MAP Kinase Kinase Kinases - genetics</topic><topic>MAP Kinase Kinase Kinases - metabolism</topic><topic>MAP Kinase Signaling System - drug effects</topic><topic>MAP Kinase Signaling System - genetics</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Mitogen-Activated Protein Kinase 3 - genetics</topic><topic>Mitogen-Activated Protein Kinase 3 - metabolism</topic><topic>Molecular Bases of Disease</topic><topic>Necrosis (Necrotic Death)</topic><topic>Neutrophil Infiltration - drug effects</topic><topic>Neutrophil Infiltration - genetics</topic><topic>Neutrophils - enzymology</topic><topic>Neutrophils - pathology</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sanz-Garcia, Carlos</creatorcontrib><creatorcontrib>Ferrer-Mayorga, Gemma</creatorcontrib><creatorcontrib>González-Rodríguez, Águeda</creatorcontrib><creatorcontrib>Valverde, Ángela M.</creatorcontrib><creatorcontrib>Martín-Duce, Antonio</creatorcontrib><creatorcontrib>Velasco-Martín, Juan P.</creatorcontrib><creatorcontrib>Regadera, Javier</creatorcontrib><creatorcontrib>Fernández, Margarita</creatorcontrib><creatorcontrib>Alemany, Susana</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sanz-Garcia, Carlos</au><au>Ferrer-Mayorga, Gemma</au><au>González-Rodríguez, Águeda</au><au>Valverde, Ángela M.</au><au>Martín-Duce, Antonio</au><au>Velasco-Martín, Juan P.</au><au>Regadera, Javier</au><au>Fernández, Margarita</au><au>Alemany, Susana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sterile Inflammation in Acetaminophen-induced Liver Injury Is Mediated by Cot/tpl2</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2013-05-24</date><risdate>2013</risdate><volume>288</volume><issue>21</issue><spage>15342</spage><epage>15351</epage><pages>15342-15351</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Cot/tpl2 (MAP3K8) activates MKK1/2-Erk1/2 following stimulation of the Toll-like/IL-1 receptor superfamily. Here, we investigated the role of Cot/tpl2 in sterile inflammation and drug-induced liver toxicity. Cot/tpl2 KO mice exhibited reduced hepatic injury after acetaminophen challenge, as evidenced by decreased serum levels of both alanine and aspartate aminotransferases, decreased hepatic necrosis, and increased survival relative to Wt mice. Serum levels of both alanine and aspartate aminotransferases were also lower after intraperitoneal injection of acetaminophen in mice expressing an inactive form of Cot/tpl2 compared with Wt mice, suggesting that Cot/tpl2 activity contributes to acetaminophen-induced liver injury. Furthermore, Cot/tpl2 deficiency reduced neutrophil and macrophage infiltration in the liver of mice treated with acetaminophen, as well as their hepatic and systemic levels of IL-1α. Intraperitoneal injection of damage-associated molecular patterns from necrotic hepatocytes also impaired the recruitment of leukocytes and decreased the levels of several cytokines in the peritoneal cavity in Cot/tpl2 KO mice compared with Wt counterparts. Moreover, similar activation profiles of intracellular pathways were observed in Wt macrophages stimulated with Wt or Cot/tpl2 KO damage-associated molecular patterns. However, upon stimulation with damage-associated molecular patterns, the activation of Erk1/2 and JNK was deficient in Cot/tpl2 KO macrophages compared with their Wt counterparts; an effect accompanied by weaker release of several cytokines, including IL-1α, an important component in the development of sterile inflammation. Taken together, these findings indicate that Cot/tpl2 contributes to acetaminophen-induced liver injury, providing some insight into the underlying molecular mechanisms.
Background: MAP3K8 (Cot/tpl2) activates MKK1/2-Erk1/2 upon stimulation of receptors from the Toll-like/interleukin-1 receptor superfamily.
Results: Cot/tpl2 plays an essential role in acetaminophen-induced liver injury by modulating the generation of inflammatory signals induced by necrotic cells.
Conclusion: Sterile inflammatory processes triggered by tissue damage are modulated by Cot/tpl2.
Significance: Cot/tpl2 contributes to the development of pathologies associated with inflammation triggered by damage-associated molecular patterns.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23572518</pmid><doi>10.1074/jbc.M112.439547</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9258 |
ispartof | The Journal of biological chemistry, 2013-05, Vol.288 (21), p.15342-15351 |
issn | 0021-9258 1083-351X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3663553 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Acetaminophen - adverse effects Acetaminophen - pharmacology Alanine Transaminase - blood Alanine Transaminase - genetics Analgesics, Non-Narcotic - adverse effects Analgesics, Non-Narcotic - pharmacology Animals Aspartate Aminotransferases - blood Aspartate Aminotransferases - genetics Cell Line, Transformed Chemical and Drug Induced Liver Injury - enzymology Chemical and Drug Induced Liver Injury - genetics Chemical and Drug Induced Liver Injury - pathology Cytokine Drug Action ERK Hepatocyte Inflammation Interleukin-1alpha - genetics Interleukin-1alpha - metabolism Leukocyte Liver - enzymology Liver - pathology Liver Injury Macrophages Macrophages - enzymology Macrophages - pathology MAP Kinase Kinase 4 - genetics MAP Kinase Kinase 4 - metabolism MAP Kinase Kinase Kinases - genetics MAP Kinase Kinase Kinases - metabolism MAP Kinase Signaling System - drug effects MAP Kinase Signaling System - genetics Mice Mice, Knockout Mitogen-Activated Protein Kinase 3 - genetics Mitogen-Activated Protein Kinase 3 - metabolism Molecular Bases of Disease Necrosis (Necrotic Death) Neutrophil Infiltration - drug effects Neutrophil Infiltration - genetics Neutrophils - enzymology Neutrophils - pathology Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins - metabolism |
title | Sterile Inflammation in Acetaminophen-induced Liver Injury Is Mediated by Cot/tpl2 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T05%3A22%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sterile%20Inflammation%20in%20Acetaminophen-induced%20Liver%20Injury%20Is%20Mediated%20by%20Cot/tpl2&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Sanz-Garcia,%20Carlos&rft.date=2013-05-24&rft.volume=288&rft.issue=21&rft.spage=15342&rft.epage=15351&rft.pages=15342-15351&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M112.439547&rft_dat=%3Cpubmed_cross%3E23572518%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/23572518&rft_els_id=S0021925820460697&rfr_iscdi=true |